Choral Singing For the Prevention of Dementia

March 29, 2018 updated by: Feng Lei, National University, Singapore

Choral Singing For the Prevention of Dementia: A Randomized Controlled Trial

To evaluate the efficacy of choral singing in the prevention of dementia and examine the underlying mechanisms using Magnetic Resonance Imaging (MRI) technique and a panel of peripheral biomarkers in venous blood and urine. The investigators hypothesize that Choral singing could prevent cognitive decline among community-dwelling elderly who are at high risk of dementia. The underlying neural mechanisms involve the changes in brain structure and function that can be quantified using MRI technique. The changes in cognitive outcomes will be accompanied by observable changes from a panel of carefully selected peripheral biomarkers.

Study Overview

Detailed Description

Cognitive function declines with advancing age and the prevalence and incidence of dementia rises dramatically in later life. Impaired cognitive function limits one's ability to work, live and socialize, and represent a major obstacle for active aging. Data from Asian countries showed a clear role of cognitive function in contributing to functional disability independent of physical health. How to maintain good cognitive health in the later stage of life is an important and challenging question that requires well-founded research with good applicability. With no cure for dementia in sight presently, it is vitally important to find effective preventive measures. Candidates and potential avenues for intervention should be carefully evaluated in well-designed randomized controlled trials (RCT). Here the investigators propose choral singing as a novel approach for the prevention of cognitive decline and dementia; the investigators plan to test the hypothesized efficacy in a RCT based on a selected group of senior Singaporeans from the Jurong Area. This proposed research is built on a growing body of research evidence on the role of choral singing in health promotion and psychological wellbeing; and the fact that no trial has tested the potential effectiveness of choral singing in delaying cognitive decline and the onset of dementia.

The plasticity of the brain forms the scientific basis for the potential efficacy of choral singing in preventing cognitive decline and the incidence of dementia. It is well known that participating in various cognitive, social and productive activities is associated with improved cognitive function and lower risk of dementia. The protective effects on cognition may be particularly effective for certain subgroups. For example, analysis of local data showed that among the single and widowed elderly, an increase in social engagement was associated with a lower risk of cognitive impairment: compared with subjects in the lowest tertile of social engagement scores, the adjusted Odds Ratio (OR) of cognitive impairment was 0.50 for subjects in the second or the third tertile.

Data from previous clinical trials support that cognitive training is effective in improving cognitive function or delaying cognitive decline in the elderly. Functional gains from cognitive training have been reported to last up to five years, with a meta-analysis demonstrating that the protective effects of cognitive training on cognition in healthy elderly can persist years after training. In Singapore, a brain-computer interface based cognitive training system showed promise in improving memory and attention in healthy elderly. Specifically, the training led to significant improvement in immediate memory (p = 0.038), visuospatial/constructional (p = 0.014), attention (p = 0.039), and delayed memory (p<0.001) scores. However, cognitive training based on human trainer or brain-computer interface are expensive and hence the applicability as a preventive in real world setting for the general population is largely limited. Participants of such trainings also may not be able to maintain lasting interest and motivation. Given those considerations, relatively cost-effective and captivating methods are urgently needed and we believe choral singing is a promising candidate.

In Singapore, there are more than 200 school choirs. Most universities and tertiary education institutions have choirs developed as an expressive art form. Furthermore, there are numerous church choirs who sing with spiritual passion, and the professional choruses who are selected to sing and to perform. The existing resource can be tapped on in the future for large scale interventional initiative once solid data of its efficacy are produced from rigorously designed clinical studies.

In this collaborative research project that involves experts from multiple disciplines, the investigators propose to conduct a randomized clinical trial to examine the clinical efficacy of choral singing in the prevention of cognitive decline and dementia. As a cognitive stimulating activity, choral singing involves cognitive processes such as attention, memory, executive function and language. As a social activity, choral singing consists of group interactions which cultivate the feeling of being part of a meaningful community. Prior studies have demonstrated that situations and activities involving synchrony with others induces feelings of closeness and affiliation, and bolsters coordination with synchronization partners. Increased prosociality and conformity produced by synchrony may also be applied to other people more generally, even those who were not synchronization partners. Moreover, synchrony and affiliative orientations also share a bi-directional relationship, such that individuals who are more prone to prosocial tendencies are more likely to synchronize with others. As a physical exercise, choral singing requires the involvement of more than 100 muscles; it helps to improve lung function and circulation, promotes superior posture, and boost balance and resistance. Choral singing also requires the choristers to cooperate with each other, the discipline of listening to blend with fellow singers and need persistently hard work to stay on par with the level of other singers. All the above may contribute to long term cognitive benefits of choral singing.

Although theoretically plausible, the effectiveness of choral singing in preventing cognitive decline and dementia has not been studied scientifically. This proposed study will fill an important knowledge gap. The investigators aim to produce firm data on two year efficacy of choral singing in preventing cognitive decline and this will form the evidence base for further research and future interventional initiative.

Study Type

Interventional

Enrollment (Anticipated)

360

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Singapore, Singapore, 648886
        • Recruiting
        • TaRA@JP
        • Contact:
        • Principal Investigator:
          • Lei Feng, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Community-living elderly aged 60 years and above, and
  2. Subjective cognitive complaints based on self-report, or
  3. Objective cognitive impairment based on neuropsychological test scores (Z score < 0 and >-1.5), or
  4. Multiple risk factors of dementia such as family history, depression, etc., and
  5. Not demented: Clinical Dementia Rating (CDR) global score=0

Exclusion Criteria:

  1. Any terminal illness, OR
  2. Stroke, OR
  3. Aphasia, OR
  4. Marked hearing impairment, OR
  5. Participating in another interventional study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention arm
Choral Singing
Weekly sessions at 1 hour of choral singing.
ACTIVE_COMPARATOR: Control arm
General Health Education Program and Group Activities
Weekly session at 1 hour of health education talk and group activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in cognitive performance
Time Frame: Baseline, 1 year, 2 year
Measured using a composite cognitive test score based on results from a battery of 6 cognitive tests that measures the performance on multiple cognitive domains. The composite cognitive test score (CCTS) will be calculated as the average of Z scores standardised to the baseline mean and standard deviation of trial participants, with higher scores representing better cognitive performance.
Baseline, 1 year, 2 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in brain structure and function
Time Frame: Baseline, 1 year, 2 year
Measured using brain magnetic resonance imaging (MRI)
Baseline, 1 year, 2 year
Changes in biological markers
Time Frame: Baseline, 1 year, 2 year
Measured using biological sampling
Baseline, 1 year, 2 year
Depressive symptoms
Time Frame: Baseline, 6 month, 1 year, 2 year
Measured using the Geriatric Depression Scale (GDS-15)
Baseline, 6 month, 1 year, 2 year
Anxiety symptoms
Time Frame: Baseline, 6 month, 1 year, 2 year
Measured using the Geriatric Anxiety Inventory (GAI)
Baseline, 6 month, 1 year, 2 year
Stress
Time Frame: Baseline, 6 month, 1 year, 2 year
Measured using the Perceived Stress Scale (PSS)
Baseline, 6 month, 1 year, 2 year
Sleep quality
Time Frame: Baseline, 6 month, 1 year, 2 year
Measured using the Pittsburgh Sleep Quality Index (PSQI)
Baseline, 6 month, 1 year, 2 year
Neuropsychiatric symptoms
Time Frame: Baseline, 6 month, 1 year, 2 year.
Measured using the Neuropsychiatric Inventory (NPI)
Baseline, 6 month, 1 year, 2 year.
Changes in Rey Auditory Verbal Learning Test
Time Frame: Baseline, 1 year, 2 year
Measured using Rey Auditory Verbal Learning Test (RAVLT)
Baseline, 1 year, 2 year
Changes in Digit Span
Time Frame: Baseline, 1 year, 2 year
Measured using Digit Span Task
Baseline, 1 year, 2 year
Changes in Block Design
Time Frame: Baseline, 1 year, 2 year
Measured using Block Design Test
Baseline, 1 year, 2 year
Changes in Color Trails
Time Frame: Baseline, 1 year, 2 year
Measured using Color Trails tests
Baseline, 1 year, 2 year
Changes in Symbol Digit Modality
Time Frame: Baseline, 1 year, 2 year
Measured using Symbol Digit Modality Test (SDMT)
Baseline, 1 year, 2 year
Changes in Boston Naming
Time Frame: Baseline, 1 year, 2 year
Measured using Boston Naming Test
Baseline, 1 year, 2 year
Severity of symptoms of dementia
Time Frame: Baseline, 1 year, 2 year
Measured using the Clinical Dementia Rating (CDR)
Baseline, 1 year, 2 year
Changes in Mini-Mental State Examination
Time Frame: Baseline, 6 month, 1 year, 2 year
Measured using the Mini-Mental State Examination (MMSE)
Baseline, 6 month, 1 year, 2 year
Changes in Montreal Cognitive Assessment
Time Frame: Baseline, 6 month, 1 year, 2 year
Measured using the Montreal Cognitive Assessment (MoCA)
Baseline, 6 month, 1 year, 2 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lei Feng, Medicine, National University, Singapore

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2015

Primary Completion (ANTICIPATED)

December 1, 2019

Study Completion (ANTICIPATED)

December 1, 2019

Study Registration Dates

First Submitted

September 19, 2016

First Submitted That Met QC Criteria

September 27, 2016

First Posted (ESTIMATE)

September 29, 2016

Study Record Updates

Last Update Posted (ACTUAL)

April 2, 2018

Last Update Submitted That Met QC Criteria

March 29, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Choral Singing

3
Subscribe